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Abstract
Background: Histone post-translational modifications (PTMs) constitute a branch of epigenetic mechanisms that
can control the expression of eukaryotic genes in a heritable manner. Recent studies have identified several PTM-
binding proteins containing diverse specialized domains whose recognition of specific PTM sites leads to gene
activation or repression. Here, we present a high-throughput proteogenomic platform designed to characterize the
nucleosomal make-up of chromatin enriched with a set of histone PTM binding proteins known as histone PTM
readers. We support our findings with gene expression data correlating to PTM distribution.
Results: We isolated human mononucleosomes bound by the bromodomain-containing proteins Brd2, Brd3 and
Brd4, and by the chromodomain-containing heterochromatin proteins HP1b and HP1a. Histone PTMs were
quantified by mass spectrometry (ChIP-qMS), and their associated DNAs were mapped using deep sequencing. Our
results reveal that Brd- and HP1-bound nucleosomes are enriched in histone PTMs consistent with actively
transcribed euchromatin and silent heterochromatin, respectively. Data collected using RNA-Seq show that Brd-
bound sites correlate with highly expressed genes. In particular, Brd3 and Brd4 are most enriched on nucleosomes
located within HOX gene clusters, whose expression is reduced upon Brd4 depletion by short hairpin RNA.
Conclusions: Proteogenomic mapping of histone PTM readers, alongside the characterization of their local
chromatin environments and transcriptional information, should prove useful for determining how histone PTMs
are bound by these readers and how they contribute to distinct transcriptional states.
Background
A cell’s transcriptional program is governed not only by
cis-acting DNA sequences, but also by chromatin structure,
DNA methylation and histone post-translational modifica-
tions (PTMs). Chromatin modifications and the gene
expression patterns that accompany them are maintained
when a cell divides and are thus known as ‘epigenetic’ [1,2].
Histone lysine methylation is associated with both tran-
scribed and non-transcribed chromatin. For example,
H3K4me3 is found in the 5’ region of active genes, whereas
H3K36me2 and H3K36me3 are enriched within the body
and the 3’ end of active genes, respectively [3,4]. However,
H3K9 and H3K27 trimethylation are implicated in both
the formation and spreading of constitutive heterochro-
matin and silencing of euchromatin. In contrast to methy-
lation, histone H3 and H4 acetylation is a general
characteristic of transcriptionally active chromatin.
Depending on the residue modified, acetylations can be
localized to nucleosomes near the 5’ promoter region or
enriched throughout coding regions of actively transcribed
genes. For instance, chromatin immunoprecipitation
experiments have shown that H3K27ac and H3K14ac are
enriched on only a few nucleosomes at the promoters of
active genes, whereas H4 acetylations correlate with large
euchromatic regions containing transcribed loci [3,5].
The ‘histone code’ hypothesis proposes that specific his-
tone PTMs encode regulatory information that is read by
the binding of accessory proteins. These accessory pro-
teins, termed ‘readers’, bind via specialized histone-PTM-
binding domains such as bromodomains, chromodomains
and plant homeodomains (PHDs) [1]. The bromodomain
binds directly to acetylated lysines in histones and is
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commonly found in proteins associated with gene activa-
tion, such as Brg1, a subunit of the hSWI/SNF remodeling
complex, the acetyltransferase hGcn5, and the Brd pro-
teins, which are mammalian homologs of the Drosophila
trithorax Fsh1 and Fsh2 proteins [6]. The Brd2, Brd3 and
Brd4 proteins are referred to as BET proteins as they con-
tain tandem bromodomains and an extraterminal domain
of unknown function [7]. In vitro studies have demon-
strated that Brd2 and Brd3 possess nucleosome chaperone
activities that allow RNA polymerase II to elongate tran-
scripts through hyperacetylated nucleosomes, implicating
their direct role in transcription [8]. Several reports have
also implicated Brd regulation of cell cycle progression
and inflammatory response [9,10]. Thus, the unique pro-
tein architecture and function of Brd proteins qualify
them as promising targets for selective pharmacological
inhibitors such as immunosuppressants and anticancer
drugs. In fact, recent publications have reported two Brd
protein selective small molecule inhibitors (I-BET and
JQ-1) that specifically inhibit bromodomain binding to
acetylated histones, thereby blocking a lipopolysaccharide-
induced cytokine storm and the growth of Brd-dependent
tumors [9,11].
In contrast to bromodomains, chromodomains are
methyl-lysine binding domains found in proteins such as
the heterochromatic proteins HP1a and HP1b that bind
to H3K9me3 [12]. Chromodomains are also found in the
polycomb group, CBX proteins, which mediate silencing
by packaging specifically methylated nucleosomes into
heterochromatin-like clusters [13]. In addition to a chro-
modomain, HP1a and HP1b contain a chromoshadow
domain thought to be involved in interactions with other
proteins [14]. The HP1a and HP1b proteins form both
homo- and heterodimers, and although these proteins
colocalize at many heterochromatic loci, they also bind to
distinct loci [15].
Here, we report experiments that elucidate the combina-
tions of histone PTMs on nucleosomes associated with the
histone code reading proteins Brd2, Brd3, Brd4, HP1a and
HP1b (Figure 1a), applying a chromatin immunoprecipita-
tion quantitative mass spectrometry (ChIP-qMS)
approach. We also utilized deep sequencing to map the
DNA sequences contained within these nucleosomes to
their genomic locations and used RNA sequencing and
microarrays to determine the transcriptional state of the
nucleosomes. Knockdown of Brd4 or HP1b suggests that
the proper expression of many genes is dependent on
their associated Brd or HP1 proteins. Providing genomic
maps of where histone code readers are bound and the
modifications found on such nucleosomes lays down the
foundation that will aid future work aimed at deciphering
how the network of chromatin-associated proteins ‘trans-
late’ these histone PTMs. Additionally, these proteomic
ChIP-qMS methods can be generally applied to any
chromatin binding protein to characterize their local chro-
matin environments and identify enriched histone PTM
patterns. Combined with further downstream analyses we
are able to correlate this information to transcriptional
states.
Results
To gain insight into the local chromatin make-up of his-
tone PTM binding proteins, we optimized a ChIP techni-
que to purify mononucleosomes from cells expressing
tagged chromodomain- and bromodomain-containing
proteins. Specifically, we generated HEK293 cell lines that
express FLAG-tagged fusions of Brd2, 3, 4 and HP1a and
b (Figure 1a), as these bromodomain- and chromodomain-
containing proteins are believed to mitigate opposing
epigenetic functions and could provide solid proof of prin-
ciple experiments. Western blots (Additional file 1) show
that our transiently expressed proteins are above endogen-
ous. As outlined in Figure 1b, following nuclear isolation
and micrococcal nuclease digestion, nucleosomes bound
by the various FLAG-tagged proteins were immunopreci-
pitated and competitively eluted with excess FLAG pep-
tide. Figure 1c shows that FLAG-tagged Brds and HP1s all
immunoprecipitate the core histones while no histones
were detected from cells not expressing a FLAG-tagged
protein. We find that competitive elution with FLAG pep-
tide reduces non-specific binding compared to boiling the
beads in SDS buffer. Immunoprecipitates from FLAG-
tagged HP1a and HP1b contained other abundant poly-
peptides, such as Tif1b protein, a heterochromatic protein
that is known to interact and colocalize with HP1a and b
[16,17]. Interestingly, Tif1b contains a bromodomain and
PHD domain (Figure 1a), which may allow for a more
complex histone code to be read when in complex on a
nucleosome with HP1. The immunoprecipitated histones
were then derivatized with propionic anhydride, trypsi-
nized, and subjected to qMS via nano scale liquid chroma-
tography-tandem mass spectrometry (nanoLC-MS/MS)
experiments on an Orbitrap instrument [18]. The derivati-
zation allows for the incorporation of isotopically stable
d0- or d5-propionyl groups such that two samples (each
labeled with a different isotope) can be analyzed together
in a single nanoLC-MS/MS experiment (Figure 2a) or
samples can be both labeled with d0-propionyl and run
individually. The histone modifications found on H3 and
H4 peptides from a ChIP-qMS and whole-genome control
are then quantified using in-house developed software (see
Materials and methods) as depicted in Figures 2 and 3.
Characterization of PTMs on histone H4 from Brd- and
HP1-associated nucleosomes
PTMs observed on the H4 molecules from Brd-bound
nucleosomes contained marks consistent with gene acti-
vation. Most striking was the enrichment in the overall
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Figure 1 Isolation of Brd- and HP1-bound mononucleosomes. (a) Illustration of the domain architecture of the histone code readers. (b)
Schematic of protocol used to isolate nucleosomes bound to FLAG-histone code readers (HCRs). (c) Visualization of FLAG-Brd- and FLAG-HP1-
bound nucleosome purifications. The proteins present in the input (I), the immunoprecipitation unbound (U), and FLAG-peptide-eluted (E),
fractions were examined by SDS-PAGE and Coomassie blue staining. The asterisk denotes Brd3 breakdown products detected by liquid
chromatography-tandem mass spectrometry.
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Figure 2 Histone H3 and H4 residue-specific PTMs quantified by mass spectrometry. (a) Total ion chromatogram and full MS spectrum of
propionylated histone peptides used for quantification from an HP1b ChIP; ChIP elution D0 labeled (black), and the control ChIP input D5
labeled (red). Full MS spectrum of peptides shown; H3K9me3K14un, H3K9me1K14un, H4K5unK8unK12acK16ac, H3K18unK23me1 and H3K79me3.
(b) Quantification of the degree of acetylation of the histone H4 peptide (amino acids 4 to 17, GKGGKGLGKGGAKR). Values in the table are the
total percentage of each acetylated form and the heatmap is a representation of the fold change of the specified ChIP/Input in (log2) scale.
(c) Heatmap depicting all modifications quantified on the histone H3 and H4 proteins. Values used to generate the heatmap are found in
Additional file 2. The heatmap was generated with the fold change values of each PTM for each specified ChIP/Input in (log2) scale.
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Figure 3 Quantification of PTMs on histone H3 and H4 peptides isolated with HP1 and Brd proteins. (a) Heatmap depicting all modified
forms of H3 peptides on HP1- and Brd-bound nucleosomes by qMS. Values used to generate the heatmap are in Additional files 2 and 6. The
heatmap was generated with the fold change values for each modified H3 peptide quantified from each specified ChIP/Input in (log2) scale. (b)
Heatmap depicting all modified forms of H4 peptides on HP1- and Brd-bound nucleosomes by mass spectrometry. Values used to generate the
heatmap are in Additional files 2 and 3. The heatmap was generated with the fold change values for each modified H4 peptide quantified from
each specified ChIP/Input in (log2) scale.
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degree of acetylation. All the potentially acetylated
lysines (K5, K8, K12 and K16) occur on the same pro-
pionylated tryptic peptide, so we first quantified H4
tail peptides that were unmodified, mono, di-, tri- and
tetra-acetylated, irrespective of the residue modified
(Figure 2b, table). When compared to whole genome
chromatin, all Brd nucleosomes were enriched in H4
acetyl modifications; 1.3- to 2.3-fold for the diacetylated
species, 5.4- to 8.3-fold for the triacetylated species and
12.9- to 39.5-fold for the tetracetylated form (Figure 2b,
heatmap). Notably, the Brd nucleosomes contained only
15 to 29% unacetylated H4 molecules as opposed to
genomic histone H4, which was 50% unacetylated. As
nucleosomes contain two copies of each histone, the
unacetylated species within these nucleosomes is prob-
ably not directly bound by the Brds. On the other hand,
HP1a- and HP1b-bound nucleosomes had relatively low
levels of H4 acetyls. In fact, approximately 70% of the
H4 tails were unmodified on HP1-bound nucleosomes
(Figure 2b, table). However, the HP1 bound nucleo-
somes have moderate levels of H4 acetylation, such as
tails with a monoacetyl (approximately 25%). The single
most abundant H4 tail acetylation in HEK 293 cells is
H4K16, occurring in approximately 41% of all histone
H4 molecules (Additional file 2). This particular acetyla-
tion mark was only slightly enriched on Brd nucleo-
somes (1.2- to 1.5-fold) (Figure 2c). We suspect that Brd
proteins may not directly read this PTM; rather, its
slight enrichment in Brd nucleosomes is a consequence
of being associated with other active chromatin marks.
Nucleosomes bound by all three Brd proteins were sig-
nificantly enriched in acetylations at the other sites on
histone H4; H4K5ac (4.7- to 6.3-fold), H4K8ac (4.1- to
8.7-fold) and H4K12ac (2.3- to 3.3-fold) (Figure 2c) con-
sistent with X-ray crystallography structural studies
[19,20].
Our in-house software (see Materials and methods)
accurately deconvoluted the mixed tandem mass spectra
resulting from isobaric acetylation combinations that occur
on H4 (that is, K5, K8, K12 and K16). When compared to
whole genome chromatin, nucleosomes bound by all three
Brd proteins were enriched with the H4 diacetylated forms
(K5unK8acK12unK16ac, K5unK8acK12acK16un and
K5acK8unK12unK16ac), while only Brd3- and Brd4-bound
nucleosomes were enriched in the K5acK8unK12acK16un
species (Figure 3b, heatmap; Additional file 3). These
results suggest that Brds will tolerate H4 containing K16ac,
although it is not required for binding by the Brds. As
depicted in Figure 3b, the nucleosomes bound separately
by all three Brd family member proteins were also highly
enriched with all H4 triacetylated forms when compared to
whole-genome chromatin, such as the H4K5unK8acK12-
acK16ac (4.4- to 7.2-fold), H4K5acK8unK12acK16ac (4.7-
to 7.0-fold), H4K5acK8acK12unK16ac (4.3- to 20.3-fold)
and especially H4K5acK8acK12acK16un (11.3- to 44.9-
fold). t-Tests performed with data from three independent
experiments for each ChIP revealed that these fold changes
are indeed significant as the P-values were all <1 × 10-2
(Additional file 4). The finding that H4K5acK8acK12-
acK16un is the most enriched triacetylated H4 code further
supports the hypothesis that H4K16 acetylation is not a
Brd binding site. The tetracetylated H4 code, H4K5acK8-
acK12acK16ac, is found on 0.5% of all H4 in whole genome
chromatin in HEK 293 cells; however, this form is strik-
ingly enriched in nucleosomes bound by all three Brds -
Brd2 (20.8%), Brd3 (6.8%) and Brd4 (9.3%) - and nearly
undetectable in HP1-bound nucleosomes. Moreover, HP1
nucleosomes were depleted of most combinatorial forms of
H4 acetylations compared to whole genome chromatin
(Figure 3b).
H4K20me2 is the most abundant mark on human his-
tone H4, found on approximately 58% of all H4 in HEK
293 cells (Additional file 2), consistent with its incorpora-
tion in heterochromatin as ≥70% of mammalian genomes
are thought to be heterochromatic. H4K20me2 was
enriched in HP1-bound nucleosomes and depleted in Brd
nucleosomes (Figure 3b). H4K20me2 was especially
depleted in Brd4-bound nucleosomes (approximately 8.5%
abundance). Although this mark is extremely high in HP1-
bound nucleosomes, approximately 80% for HP1b and
approximately 73% for HP1a, we lack direct evidence to
indicate that the HP1 chromodomains are reading this
mark (Additional file 2). Similarly to H4K16ac, H4K20me2
may be part of a more complex heterochromatic histone
code recognized by an HP1 complex. Additionally, as HP1
is known to bind H3K9me3, it is reasonable to speculate
that the genomic location of this heterochromatic mark
overlaps with H4K20me2.
Characterization of PTMs on histone H3 from Brd- and
HP1-associated nucleosomes
As indicated in Figures 2c and 3a, Brd-bound nucleosomes
all have elevated levels of H3K4me1, a gene activation
mark. HP1-bound nucleosomes had relatively low levels of
this mark. Moreover, H3K4me2 and H3K4me3 were also
elevated in the Brd-bound nucleosomes and depleted in
HP1-bound nucleosomes. When compared to whole gen-
ome chromatin, nucleosomes bound by Brd2 were the
most enriched in these modifications; 12.4-fold (P-value =
0.01) for H3K4me2 and 23.6-fold (P-value = 0.0009) for
H3K4me3 (Figures 2c and 3a; Additional file 5). These
particular PTMs occur on the nucleosomes surrounding
the promoters of actively transcribed genes and are at very
low levels genome-wide (≤1%).
The chromodomains of HP1a/b bind directly to silen-
cing marks H3K9me2 and H3K9me3 [12,21]. HP1-bound
nucleosomes were enriched with both these K9 methyla-
tions (Figure 2c). For these modifications, a 1.5- to 2-fold
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increase is significant, as these modifications are extre-
mely abundant in whole-genome chromatin, 31% and
21%, respectively (Additional file 2). We also found that
Brd-bound nucleosomes were low in H3K9me3, but have
moderate levels of H3K9me2 (Figure 2c).
Another modification, H3K23me1, is also found at low
abundance (0.2%), but was highly enriched on both HP1s
(Figure 2c; Additional file 2). This result is not surprising
as a recent study employing a histone peptide methyl-
lysine array found that HP1b binds H3K23me1 in addition
to H3K9me3 [22] and colocalizes with H3K9me3 and
HP1b at heterochromatic loci. We believe that a subset of
HP1 proteins may bind H3K23me1 via its chromodomain
independent of H3K9me3 within these loci. H3K18me1 is
another modification that is of very low relative abundance
in whole genome chromatin (0.3%). Here we find that Brd-
bound nucleosomes were highly enriched with this modifi-
cation; Brd2 (5.23%), Brd3 (4.17%) and Brd4 (3.10%)
(Additional file 2). H3K18 can also be acetylated by the
CBP/p300 acetyltransferase, and H3K18ac localizes with
H3K4me3 by ChIP at the promoters of some actively tran-
scribed genes [3,23-25]. As depicted in Figure 2c, nucleo-
somes bound by Brds were enriched in H3K18ac (4.2- to
6.9-fold; P-values <0.001; Additional file 5) compared to
bulk chromatin. This result is consistent with reports that
H3K18ac localizes with H3K4me3, as Brd nucleosomes
were also enriched with H3K4me3. The nucleosomes
bound by the Brds also exhibited high levels of acetylation
at H3K9ac, H3K14ac, and H3K23ac, whereas acetylation
of these residues was reduced on HP1-associated nucleo-
somes (Figure 2c).
Two other abundant gene repressive PTMs are
H3K27me3 and H3K27me2. Nucleosomes bound by
both HP1 proteins were modestly enriched with these
modifications (Figure 2c). H3K27me3 and H3K27me2
are thought to demarcate the promoter regions and
bodies, respectively, of particular repressed genes. These
methylations are added by the polycomb group proteins
Ezh1 and Ezh2 and bound by other polycomb group
chromodomain-containing CBX proteins [26,27]. Inter-
estingly, our observation that HP1-bound nucleosomes
were enriched with H3K27me2/3 suggests that there may
be some overlap amongst heterochromatin bound by the
HP1 and polycomb CBX chromodomain proteins. Future
ChIP-seq experiments with the polycomb CBX proteins
will be required to determine their genomic overlap with
the HP1 proteins.
As some H3 PTMs can be observed on the same pep-
tides, a few combinations of PTMs were also characterized
(Additional file 6). We believe that there is useful combi-
natorial information in tandem PTMs; for example, we
previously reported that the histone H3K9 euchromatic
dimethytransferase G9a preferentially methylates H3 pep-
tides that contain K14 acetylation [28]. This modification,
H3K9me2K14ac, shares similar characteristics to the ‘biva-
lent domain’ (H3K4me3K27me3) found on silent genes
poised for activation in pluripotent stem cells, containing
PTMs with opposing epigenetic functions [29]. As men-
tioned previously, Brd-bound nucleosomes contained
some H3K9me2, but the bulk of this modification
occurred on peptides that were acetylated on the adjacent
lysine (H3K9me2K14ac), the tandem marks effected by
G9a (Figure 3a). This result is consistent with the observa-
tion that G9a localizes primarily to euchromatin, and that
H3K9me2K14ac may also act as a combinatorial switch,
similar to the bivalent domain. In contrast, H3K9me3 was
depleted in Brd nucleosomes even when H3K14 was
acetylated. On the other hand, there was substantial
amounts of this combinatorial modification, H3K9me3-
K14ac, on nucleosomes bound by HP1a (13.7%) and
HP1b (16.3%), which occurs on only 9.8% of the nucleo-
somes in the genome (Additional file 6).
Brd-bound nucleosomes also contain histone H3
enriched with other combinatorial PTMs consistent
with gene activation, such as H3K9acK14ac (2.9- to 4.6-
fold; P-values <0.038) and H3K18acK23ac (5.0- to 8.2-
fold; P-values <0.0008; Additional file 7) and are
depleted in marks that correspond with gene repression,
such as H3K9me3K14un (Figure 3c). H3K36me3 is
another modification associated with the bodies of
actively transcribed genes. We found that Brd4-bound
nucleosomes were enriched with this modification (2.2-
fold), but only when the H3K27 was monomethylated
(H3K27me1K36me3) (Figures 2c and 3a).
Chromosomal locations of Brd- and HP1-bound
nucleosomes (ChIP-Seq)
To determine where the histone code reading proteins
genomically reside, we deep sequenced the DNA iso-
lated in Brd- and HP1-bound nucleosomes (ChIP-seq)
[4]. Figure 4a shows Brd and HP1 ChIP-seq maps for
chromosomes 17, × and 12. At this level of resolution
there is much overlap of the ChIP-seq maps amongst
the three Brds and amongst the two HP1s. In agreement
with previous reports we observed a cluster of HP1
binding that mapped within the centromere region on
every chromosome [17]. HP1 binding also mapped
along the entire length of the × chromosome, which is
consistent with the fact that HEK293 cells are of female
origin, possessing an imprinted inactive × chromosome.
In contrast, Brd-binding clusters were found throughout
chromosome 17 but there are only 4 predominant HP1-
binding clusters, as this is a relatively small chromosome
that contains many active genes, including the HOXB
cluster (HOX gene clusters will be discussed later).
Other chromosomes such as chromosome 12 had a
more uniform distribution of Brd- and HP1-binding
clusters.
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Figure 4 Mapping of Brd- and HP1-bound nucleosomes to their genomic locations. (a) Chromosome maps showing the density of Brd-
and HP1-bound nucleosomes generated by Solexa Deep sequencing on chromosomes 17, × and 12. (b) Table denoting the enrichment of Brd
and HP1 nucleosomes within the genome relative to the genes. (c-g) Graphs showing the relative enrichment of Brd and HP1 nucleosomes
within genes, grouped by expression levels (high, red; medium, blue; silent, green). TES, transcription end site; TSS, transcription start site.
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At the gene level (Figure 4b), approximately 65% of Brd-
binding sites were found on genes (promoter plus gene
body). The remaining approximately 35% was found on
intergenic regions, very often in regions flanking genes.
The promoter regions as defined in this study are the
+2 kb regions upstream of the transcription start sites. We
observed that 9 to 13% of the Brd-binding sites were
found within such promoter regions. On the other hand,
HP1a and b binding sites were predominately found in
intergenic regions (73% and 66%, respectively) and rarely
on promoter regions of genes (1 to 2%). Complete lists of
promoters bound by Brd and HP1 ChIPs can be found in
Additional file 8. As shown in Figure 4c-e, patterns of Brd
binding indicate that these proteins are predominately
found on high and moderately expressed genes and rarely
on transcriptionally silent genes. Genes were ranked based
on their expression levels as determined by RNA-Seq,
where high expression is defined as the top third of the
genes, the middle third as moderate and the bottom third
as silent. As predicted, the vast majority of genes bound by
the HP1s were classified as either silent or having moder-
ate expression (Figure 4f,g). A heatmap depicting the
DNA consensus motifs enriched in the ChIPs can be
found in Additional file 9 with an accompanying list of
motifs (Additional file 10). We have also included lists of
Gene Ontology terms enriched in the Brd ChIPs (Addi-
tional file 11).
Brd-bound nucleosomes are associated with the
promoters of HOX genes
To more fully probe the genes bound by each reader, we
focused on those genes whose promoters had the most
significant binding. As shown in Figure 5a, genes were
grouped according to the combinatorial promoter binding
patterns of Brd and HP1 proteins (bound genes in red and
unbound genes in blue), and expressed and non-expressed
genes are shown in red and blue, respectively. We found
substantial co-binding of gene promoters by the Brd
proteins and a strong correlation between Brd binding
and gene expression. Considering the top 500 most Brd-
enriched gene promoters, we found a 54% overlap
amongst Brd2 and Brd3, a 35% overlap amongst Brd3 and
Brd4, and a 28% overlap between Brd2 and Brd4. As for
particular genes, we observed from an unbiased ranked
ordered list of bound promoters (Figure 5b) that an unu-
sually large number of the highest ranking promoters
bound by the Brd proteins were HOX genes. We have also
validated the binding of endogenous Brd4 to several HOX
genes (HOXB5, HOXB3, HOXC5 and HOXC11) by ChIP,
using a monoclonal antibody raised against Brd4 (Addi-
tional file 12). There are four HOX gene clusters (HOXA
to HOXD) in the human genome, each containing
between 10 and 12 protein coding Hox (homeobox) genes
as well as several microRNAs [30]. As shown in Figure 5b,
when considering the top 35 promoters bound by Brd3
and Brd4, 18 and 15, respectively, are from HOX gene
clusters. When we considered the top 100 scoring gene
promoters bound by both Brd3 and Brd4, we found in
both cases they included 15 HOX (homeobox) encoding
genes and 3 HOX cluster encoded microRNAs all found
within the HOXA, HOXB and HOXC clusters. As for
Brd2 promoter binding, we found 9 of the top 100 ranked
genes were HOX genes. Although we were surprised to
find such a huge enrichment of HOX genes in Brd ChIPs,
this result is in agreement with the fact that the Brd pro-
teins are human homologs of the Drosophila FSH-S and
FSH-L proteins, which are encoded by trithorax group
genes [6]. Trithorax group genes were originally identified
from Drosophila genetic screens as genes required for the
persistent expression of HOX genes that control the devel-
opment of body segments [31,32]. The differential expres-
sion of HOX genes is also essential for patterning of all
vertebrate embryos and the correct sustained expression
of HOX genes in different tissue types is required to main-
tain cells in their respective differentiated states [33].
Therefore, maintaining a specific chromatin architecture
at HOX gene clusters is an elegant evolutionary solution
to regulate their expression, potentially through epigenetic
regulation. Other trithorax proteins that regulate HOX
gene expression have been shown to be components of
chromatin remodeling, histone methylation and histone
acetylation complexes [34-36]. In fact, the Drosophila
trithorax acetylation complex (TAC1) and the Drosophila
Brd protein (FSH-S) are required for the expression of the
HOX gene Ubx and the overexpression of FSH-S can
induce the ectopic expression of several HOX genes in
Drosophila [6,34]. These results suggest that the histone
acetylation marks that are written by TAC1 are read and
translated by the Brd protein FSH-S.
HP1 bound nucleosomes are associated with the
promoters of ZNF genes on chromosome 19
As stated above, the HP1s were found at the promoter
regions of 1 to 2% of the genes they bind and most of
these are transcriptionally silent (Figure 4b,f,g). More-
over, neither HP1 protein was found on any HOX gene
promoters. We also did not observe an equal distribution
amongst the chromosomes with genes whose promoters
were bound by the HP1 proteins. For both HP1 proteins,
approximately 30% were found on chromosome 19 and
20% were found on the × chromosome. As shown in
Figure 5b, when we only considered the top 35 gene pro-
moters bound by HP1 proteins, HP1a and HP1b bound
18 and 15 ZNF gene promoters, respectively, from chro-
mosome 19. ZNF genes encode proteins that belong to a
large superfamily of putative transcription factors
(approximately 800 members in humans), many of which
are thought to function as transcriptional repressors [37].
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(a) (b)
(c)
Figure 5 Promoters bound by Brd- and HP1-bound nucleosomes. (a) Heatmap of promoters with nucleosomes bound by the Brd and HP1
proteins. Heatmaps are arranged as clusters of promoters bound by the various ChIPs (lanes 1 to 5: bound, red; unbound, blue) and the
expression of these genes from RNA-Seq is represented in lane 6 (high and medium, red; silent, blue). (b) Ranked order table of genes (top 35)
whose promoters are bound by the Brd and HP1 proteins. Genes are ordered based on Brd/HP1 binding score within the promoter region of all
annotated genes (top of the list, most bound). Genes belonging to the HOX clusters or ZNF clusters are color coded accordingly. (c) HP1a and
HP1b binding clusters on chromosome 19. The ZNF clusters are labeled 1 to 6.
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There are six clusters of ZNF genes found on chromo-
some 19. These clusters all span from 1 to 3 Mb of DNA
each and are located along chromosome 19 as follows:
cluster 1, 10 to 12 Mb; cluster 2, 19 to 23 Mb; cluster 3,
40 to 43 Mb; cluster 4, 49 to 50 Mb; cluster 5, 57 to 59
Mb; and cluster 6, 61 to 63 Mb (Figure 5c). When con-
sidering the top 100 bound promoters, we observed that
HP1a bound to 37 gene promoters (23 known ZNF
genes), and HP1b to 55 gene promoters (27 known ZNF
genes), all located within these clusters on chromosome
19. However, we did not see complete overlap amongst
the promoter binding of both HP1 proteins. While we
found extensive binding of HP1b to the promoters of
genes in all six clusters, HP1a was only found predomi-
nantly in clusters 3, 4 and 6, with very little binding in
the other three clusters. Interestingly, the promoters of
genes found in cluster 5 are extensively bound by HP1b
and almost completely devoid of HP1a binding. Within
this cluster, HP1b was bound to the promoters of 59
genes, 16 of which are ZNF genes, as well as a subcluster
of 20 microRNA genes in the distal half of this cluster.
These data are consistent with a study in 2006 that used
a DNA adenine methyltransferase identification (DamID)
method coupled with cDNA oligo microarrays to identify
the target genes bound by HP1b [38]. In agreement with
these findings, ChIP-seq experiments with antibodies
directed against H3K9me3 have found distinct islands of
this modification map to the ZNF clusters [4].
Brd4 is a positive regulator of the genes it binds
In order to determine whether Brds directly regulate the
expression of the genes they bind, we performed gene
expression microarrays on cells depleted of Brd4 by short
hairpin RNA (shRNA). We choose to knockdown Brd4
because it shared the least overall overlap of bound pro-
moters with the other Brd ChIPs. We achieved a three-
fold knockdown of Brd4 with a custom shRNA in
HEK293 cells as determined by RT-PCR. The knockdown
was also verified at the protein level by western blot (Addi-
tional file 13). Of the top 100 genes whose promoters were
most bound by Brd4, we found three-quarters of them had
at least a two-fold reduction in expression in the Brd4
shRNA cell line when compared to the control (Figure 6a,
right heatmap). These results suggest that the direct bind-
ing of Brd4 to the acetylated nucleosomes associated with
these genes is required for their proper expression. Only 8
of these top 100 genes showed an increase in expression
upon Brd4 depletion. We speculate that these may be the
result of downstream effects rather than a loss of Brd4
binding. Looking at the 28 HOX genes whose promoters
were significantly bound by Brd4, we found that two-
thirds of this subset of genes had reduced expression (1.5-
fold or greater; Figure 6b). Only 6 of the 28 protein coding
HOX genes had an increase in expression and 5 showed
no significant change upon Brd4 knockdown. This result
suggests that there is redundancy amongst the Brd pro-
teins, as we found overlapping binding of the Brds on
many of the HOX genes, especially between Brd3 and
Brd4.
HP1b is a negative regulator of the genes it binds
In order to determine the direct effects of HP1 binding to
nucleosomes, we preformed gene expression arrays on
HEK293 cells depleted of HP1b by shRNA. We chose to
knockdown HP1b rather than HP1a because it was
enriched on more promoters, including most of the
HP1a-bound promoters. Our custom shRNA knocked
down HP1b mRNA by 3.5-fold in HEK293 cells as deter-
mined by RT-PCR. The knockdown was also verified at
the protein level by western blot (Additional file 13). In
contrast to the effects of Brd knockdown, knockdown of
HP1b resulted in at least two-fold increases expression in
two-thirds of the top 100 HP1b promoter-bound genes
(Figure 6a, left heatmap). These results suggest that the
binding of HP1b to histone methylated nucleosomes is
required for effective silencing of associated genes. We
also looked at the expression of the ZNF genes found on
chromosome 19 whose promoters were enriched with
HP1b-bound nucleosomes (Figure 6b, left heatmap). Sur-
prisingly, we found that the expression of only one-third
of these genes significantly increased, whereas two-thirds
remained the same or decreased. This result is in agree-
ment with the aforementioned study that mapped HP1b
to the ZNF clusters on chromosome 19 with the DamID
method [38]. They also reported that individual depletion
of HP1a/b did not lead to an appreciable change in the
expression of most of the ZNF clusters. We hypothesize
that this is due to the redundancy of the three HP1s
(HP1a, b and g) and attempts to circumvent this by
depleting more than one at a time have been unsuccessful.
Also, removing the heterochromatic binding proteins
alone may not be enough to fully turn on repressed genes,
as there are other steps required for gene activation, such
as recruitment of transcription factors or gene activating
histone-modifying enzymes or other binding proteins.
This hypothesis would also be consistent with our finding
that the expression of the majority of genes whose promo-
ter regions were bound by HP1b did not change signifi-
cantly when HP1b was depleted.
Brd-bound nucleosomes are associated throughout the
body of transcribed HOX genes
Having selected for significantly bound genes based on
Brd and HP1 promoter binding, we next looked at the
binding of these proteins across the entire length of
such genes. For actively transcribed genes, we examined
Brd and HP1 binding across the HOXA10, HOXA11,
HOXB9, and HOXC10 genes and the housekeeping gene
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Figure 6 Brd4 and HP1b regulate gene expression. (a) Right panel: heatmap showing the log2 fold change in gene expression from 293
cells with depleted Brd4 compared to control 293 cells. Genes shown are the top 100 genes whose promoter regions were the most enriched
with Brd4 bound nucleosomes. Left panel: heatmap showing the log2 fold change in gene expression from 293 cells with depleted HP1b
compared to control 293 cells. Genes shown are the top 100 genes whose promoter regions were the most enriched with HP1b-bound
nucleosomes. (b) Right panel: heatmap of the log2 fold change in expression of all HOX genes with promoters bound by Brd4 in the Brd4-
depleted 293 cell line compared to control 293 cells. Left panel: heatmap of the log2 fold change in expression of all ZNF genes found on
chromosome 19 with promoters bound by HP1b in the HP1b-depleted 293 cell line compared to control 293 cells.
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ACTB (Figure 7a-d), and these genes were found to be
devoid of HP1. We also found that the expression of
these genes were all significantly reduced in the Brd4
knockdown cells: HOXA10 by 3-fold, HOXA11 by 4-
fold, HOXB9 by 2-fold, HOXC10 by 2.5-fold and ACTB
by 1.5-fold. The mRNA for the housekeeping gene
ACTB is extremely abundant, so we believe that a 1.5-
fold decrease in its expression is significant. Moreover,
the expression of this gene increased by 1.4-fold in the
HP1b kockdown cells. As shown in Figure 7a,c, binding
of all three Brds was found to be evenly distributed
throughout the promoter region and gene bodies of the
HOXA10, HOXA11 and HOXC10 genes. On the HOXB9
gene we found a huge enrichment of Brd2 and Brd3
within the promoter region (Figure 7b). Both proteins
were also bound to the body of this gene with Brd2
enrichment peaking in the later half towards the 3’
region. Brd4 binding to HOXB9 nucleosomes was evenly
distributed over the promoter region and gene body. As
for the housekeeping ACTB gene, we found that all
three Brd proteins bound within the promoter region
and the gene body with Brd2 being especially enriched
with the body of this gene. This is consistent with the
role of Brd proteins in transcriptional elongation [8,39].
Furthermore, the binding of Brd proteins to the bodies
of HOX genes is also consistent with the reported
hyperacetylation of histone H4 within the bodies of
HOXA genes upon activation with retinoic acid in pluri-
potent embryonal carcinoma cells [40].
HP1-bound nucleosomes are associated with the bodies
of transcriptionally silent ZNF genes
We next analyzed the binding patterns of HP1 proteins on
the ZNF560 and ZNF599 genes (Figure 7e,f). Both genes
were determined to be silent in control HEK293 cells by
RNA-Seq analysis (Figure 7e,f, bottom panels). ZNF560
and ZNF599 are found in the HP1-binding clusters 3 and
6 on chromosome 19, which are significantly bound by
both HP1a and HP1b. We chose these ZNF genes for
further analysis as their expression was the most upregu-
lated of all HP1-bound ZNF genes upon depletion of
HP1b by shRNA (Figure 6b). As depicted in Figure 7e,f,
both HP1s bound nucleosomes throughout the bodies and
promoter regions of ZNF599 and ZNF560, with HP1b
being slightly more enriched within the promoter and 5’
region of ZNF599. These results, along with our array ana-
lysis, suggest that the HP1 proteins directly repress the
expression of these genes. Moreover, nucleosomes found
within both of these genes are relatively devoid of binding
by all three Brds. Interestingly, we did observe a short
cluster of Brd-bound nucleosomes at the end of the
ZNF599 gene and continuing in the 3’ direction on chro-
mosome 19; however, this result is rather perplexing as
there are no actively transcribed genes in this region.
Discussion
Since the completion of the Human Genome Project in
2000, there have been several calls for a similar project to
catalog human epigenomes. In 2008 the Alliance for the
Human Epigenome and Disease (AHEAD) outlined the
need for a project to provide high-resolution epigenome
maps and suggested guidelines for the first pass of a
human epigenome reference [41]. At the heart of these
initiatives is the use of ChIPs with antibodies that recog-
nize specific PTMs. Such studies are informative; however,
ChIPs with modification-specific antibodies will only pro-
vide epigenomic maps with little knowledge on how such
information is translated. Additionally, site-specific antibo-
dies often suffer from cross-reactivity and epitope occlu-
sion. Our less biased proteomic-genomic approaches
complement such ongoing studies and shed light on how
histone PTMs are translated into transcriptional
outcomes.
Two different models have been proposed for the func-
tion of Brd proteins in transcription. In one model Brd4
recruits the transcription elongation factor pTefb to the
transcription complex at the transcription start site,
which then phosphorylates the CTD of RNA polymerase
II, leading to more processive transcript elongation [39].
In the second model, Brd proteins are recruited to acety-
lated nucleosomes via their bromodomains and facilitate
the passage of RNA polymerase II through nucleosomes
by their intrinsic chaperone activity [8]. Our ChIP-seq
results support both models as we have observed an
enrichment of the Brd proteins at both the promoter
(approximately 12%) and body (approximately 52%) of
active genes. These results suggest an equal distribution
of Brd proteins on promoter regions and gene bodies, as
we have defined promoters regions as 2 kb upstream of
the transcription start site and the average gene body is
10 to 20 kb. Moreover, the Brd-bound nucleosomes were
enriched with patterns of histone PTMs found in both
the promoter region and body of actively transcribed
genes. ChIP-seq experiments with specific antibodies
have found that the PTMs H3K9ac and H3K4me3 are
associated with only a few nucleosomes at active gene
promoters, whereas H3K79me1 and H4K20me1 are
exclusively associated with the bodies of active genes
[3,4]. When compared to whole-genome chromatin, the
Brd-bound nucleosomes were enriched in all of these
modifications, further suggesting that they represent a
mixture of promoter and gene body nucleosomes. The
Brd-bound nucleosomes were also enriched with the his-
tone PTMs H3K14ac (approximately 55%), H3K23ac
(approximately 50%), H4K12ac (approximately 50%) and
H4K16ac (approximately 55%). These modifications were
previously shown to be enriched on both the promoters
and bodies of active genes [3,4]. Our data suggest
that Brd nucleosomes are a mixture of the following:
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promoter bound with the predominant histone PTM pat-
terns H3(K4me3, K9ac, K14ac, K23ac) and H4(K5ac,
K12ac, K16ac), and gene body enriched with H3(K4me1,
K14ac, K23ac, K79me1) and H4(K8ac, K12ac, K16ac,
K20me1).
HP1-bound nucleosomes were most enriched with his-
tones containing the repressive PTMs, H3K9me2/3 (app-
roximately 85% combined) and H4K20me2/3 (approxi-
mately 75% combined). In addition to binding the ZNF
clusters of chromosome 19, our ChIP-seq results have
revealed that the HP1 proteins reside on centromeric
heterochromatin and inactive × chromatin, both of which
harbor these marks [3,4,17]. Also in line with our results,
previous ChIP-seq experiments have colocalized these
modifications to the ZNF repeat clusters on chromosome
19 [4].
Silent Hox genes are a defining hallmark of pluripotent
stem cells and their expression is tightly regulated during
differentiation [42]. The differential expression patterns
of the Hox genes are the master regulators that direct
cellular differentiation and maintain particular cell phe-
notypes [33]. In fact, all of the protein coding Hox genes
(a) (b) (c) (d)
(e) (f)
Figure 7 Brd and HP1 protein nucleosomal binding patterns of Brd4 and HP1b regulated genes. (a) HOXA10 and HOXA11. (b) HOXB9.
(c) HOXC10. (d) ACTB. (e) ZNF599. (f) ZNF560. Top panels for are the ChIP-seq results depicting the Brd and HP1 binding patterns. Bottom
panel is the RNA-Seq results representing the expression level of each gene.
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contained bivalent domains, suggesting that they are
poised for activation [29]. Moreover, another ChIP-seq
study found that nearly half of all bivalent domains were
bound by the polycomb PRC1 complex, which contains a
chromodomain protein that binds directly to H3K27me3
[43]. Such bivalent domains were defined as containing
overlapping PTMs, H3K4me3 and H3K27me3. It is yet
unknown what activating or repressive marks on histone
H4 are found within these bivalent domains. Future
experiments will be necessary to investigate whether H4
acetylations that are bound by the Brd proteins are also
present in bivalent domains. If so, it will be interesting to
investigate whether Brd proteins are also bound to biva-
lent domain chromatin concurrent with the PRC1 bind-
ing or whether PRC1 complex is released prior to H4
acetylation and Brd binding upon gene activation. In con-
clusion, the proteomic and genomic techniques pre-
sented here can be used to probe the local chromatin
environment bound by any chromatin-associated protein.
In particular, we have examined the chromatin from
genomic regions where bromodomain- or chromodo-
main-containing proteins are found, and quantified the
histone PTMs present. These data can be used to gener-
ate hypotheses on how chromatin-associated proteins (or
histone code readers) could influence the transcription of
specific genes, hence yielding glimpses into how histone
codes could be translated. Such experimental approaches
could also be applied to any of the histone code readers
in systems of biomedical importance, such as during




Mononucleosomes were purified after (micrococcal
nuclease) Mnase digestion with FLAG-Brd or FLAG-HP1
proteins as described in [8] from HEK293 cells. FLAG-
HP1 vectors were described in [44]. All proteins were
generated by transient expression as previously described
[8,44], and expression assessed by western blots as shown
in Additional file 1. The quality of the ChIPs was ana-
lyzed by 17% SDS-PAGE and Coommassie blue staining.
The histone protein ChIP inputs and elutions were pro-
pionyl derivatized with either ‘light’ d0- or ‘heavy’ d10-
propionic anhydride, trypsinized and prepared for mass
spectrometry as previously described in [18] with minor
adjustments. 2-Propanol was substituted for methanol
during the derivatization reaction as we have found that
methanol can modify peptides at low pH.
Liquid chromatography-mass spectrometry-based
proteomics
Histone peptides were separated by reverse phase
nanospray liquid chromatography on C18 resin with an
Agilent 1200 series HPLC. Mass spectrometry was
performed on a LTQ-Orbitrap mass spectrometer
(ThermoFisher Scientific Inc. Waltham, MA, USA as
previously described [18].
Mass spectrometry data analysis
The LC-MS/MS data sets were analyzed using in-house
software. Briefly, the characterization of the histone
PTMs was performed using an optimization-based algo-
rithmic framework that simultaneously utilizes mass
spectrometry, MS/MS and chromatographic information
to identify and quantify the PTMs on the histone
peptides. The method automatically considers multiple
charge states of all modified peptides and is able to
resolve mixed tandem mass spectra resulting from co-
eluting and isobaric modified peptides using a superposi-
tion method, as previously described [45]. The statistical
significance of the relative abundance of histone modifi-
cations in various ChIPs as compared to the relative
abundance of genomic histone PTMs was calculated
using a two-tailed, unpaired Student’s t-test, and the
associated P-values were generated using Microsoft
Excel. Mass spectrometric data were converted from
RAW format into mzXML format using ReAdW. The
mzXML files were deposited into the Tranche repository
and are available for download from the Proteome
Commons [46].
Preparation of DNA for deep sequencing analysis
Nucleosomal DNAs were treated with alkaline phosphatase
to remove the 3’ phosphates left after MNase digestion and
purified by phenol extraction. The DNA fragments
(approximately 1 μg) were further prepared using the
Solexa® Illumina library kit directly following the manufac-
turer’s protocol. The purified DNA was used directly
for cluster generation and sequencing using a Solexa 1G
Genome Analyzer (Illumina).
Preparation of RNA for RNA-Seq analysis
The raw sequence data for the RNA-Seq in HEK293
cells were obtained from [47] (Gene Expression Omni-
bus sample ID GSM301568). The RNA preparation and
sequencing protocols for this RNA-Seq data can be
found in [47].
Deep sequencing analysis
The raw sequence reads were aligned to the hg18
human genome using the Bowtie short read aligner [48].
To avoid possible PCR artifacts, we kept at most one
uniquely aligned read at each genomic location per
strand. To determine the number of ChIP-Seq sequen-
cing reads in a genomic interval, we shifted the locations
of forward and reverse strand tags by 75 bp, half the size
of the nucleosomal DNA.
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For the chromosomal binding patterns of Brd and HP1
proteins (Figures 4a and 5c), reads were counted in slid-
ing windows of 1 Mb with a step size of 100 kb. The read
counts were normalized to the sequencing depth of 5 mil-
lion non-redundant reads. The signal level in each 1-Mb
window was computed as the difference between the nor-
malized read counts in the window in the sample and the
control libraries (Nsample - Ncontrol) with the negative
values set to zero. A clustering approach described in
[49] was used to identify Brd and HP1 protein-enriched
domains (’islands’) in the human genome from the ChIP-
Seq data. The percentage overlap (Figure 4b) of the Brd
and HP1 islands with the promoter, the gene-body and
the inter-genic regions were determined using the gene
annotations from the Ensembl database.
The sequence read density (per 100-bp window and
5 million non-redundant reads) was determined along
the gene body and in the upstream/downstream 2-kb
regions in the sample and control libraries. The signal
level in each window was computed as the difference
between the read densities in the sample and control
libraries, with the negative values set to zero. Genes
were ranked based on their expression levels estimated
as reads per kilobase per million mapped reads (RPKM
[50] and stratified into three expression groups: the
‘silent’ group (the bottom 30% genes in the ranked list),
the ‘high’ group (the top 30% genes), and the ‘medium’
group (the remaining genes). The mean signal levels
over all genes in each group were determined and are
displayed as gene-body plots in Figure 4c-g.
The patterns of the combinatorial binding of Brd and
HP1 proteins to the gene promoters and their correlation
to the gene expression levels were determined as follows.
A gene promoter, defined as a 2-kb region upstream of
the transcription start site, is deemed bound by the pro-
tein if the island (determined as described above) over-
laps the promoter. Genes with a particular combinatorial
promoter-binding pattern of the five proteins (such as
‘red-red-red-blue-blue’ in Figure 5a) were grouped. The
groups were then ranked based on the number of their
member genes and displayed in the descending order in
Figure 5a (except for the most populous group, ‘blue-
blue-blue-blue-blue’, displayed at the bottom). The
expression status of each gene is indicated as expressed
(’red’) if its RPKM value is at least 1 and not expressed
(’blue’) otherwise. The UCSC genome browser [51]
bedGraph files displayed in Figure 7a-f were generated as
follows. For the ChIP-Seq data, the 75-bp-shifted non-
redundant reads were counted in 200-bp tiling windows
along the genome and the read counts were normalized
to a library size of 5 million non-redundant uniquely
mapped reads in each library. For the RNA-Seq data, the
centers of the reads were counted in 20-bp tiling win-
dows along the human genome. We deposited raw and
analyzed ChIP-Seq and microarray data in the Gene
Expression Omnibus [52].
Brd4 and HP1b knockdown cells
HEK293 cells were infected with lentiviral MISSION®
(Sigma-Aldrich Corporation, St. Louis, MO, USA) shRNA
vectors (pLKO.1-puro) harboring shRNAs to Brd4 (clone
TRCN0000062223), HP1b (clone TRCN0000021427) or
control (empty pLKO.1-puro vector). After 72 hours the
infected cells were selected with puromycin according to
the manufacturer’s protocols (Sigma Aldrich). Knock-
downs of target RNAs were analyzed by qRT-PCR. For
qRT-PCR, RNA from cells was purified with an RNeasy
kit (Qiagen) and prepared with a cDNA synthesis kit (Invi-
trogen Carlsbad, CA, USA). qRT-PCR reactions were per-
formed with SYBR FAST qPCR supermix (KAPA
Biosystems Woburn, MA, USA).
Microarray analysis
RNA was extracted and purified with an RNeasy kit (Qia-
gen) from Brd4, HP1b and control shRNA knockdown
HEK293 cells. For each sample 400 ng RNA was linearly
amplified and labeled with Cy5-CTP using Low RNA
Linear Amplification reagents (Agilent Technologies
Santa Clara, CA, USA). Reference RNA from wild-type
HEK293 cells was purified, amplified and labeled with
Cy3 in the same manner. Equal quantities of the Cy5-
and Cy3-labeled cRNAs were mixed and competitively
hybridized to human GE 4x44K microarrays (Agilent,
G4112F) for 18 h using an Agilent hybridization kit.
Slides were washed according to the manufacturer’s pro-
tocols and scanned using an Agilent G2565BA scanner.
Raw image data were extracted and subjected to standard
background subtraction and linear and lowess normaliza-
tion using Agilent Feature extraction software v9.5. Heat-
maps were generated using MATLAB® software
(MathWorks Natick, MA, USA). More detailed methods
are described in Additional file 14.
Additional material
Additional file 1: Western blots of whole cell extracts from cell lines
expressing FLAG-Brd4, FLAG-HP1b and control cell line (empty
vector). Blots were probed with anti-Brd4 (mAb Epitomics, 5716
Burlingame, CA, USA), anti-HP1b (pAb Cell Signaling Technology 2613
Danvers, MA, USA) and b-actin control (mAb Santa Cruz, sc-81178 Santa
Cruz, CA, USA).
Additional file 2: Table of relative PTM abundances determined by
quantitative mass spectrometry on histones H3 and H4 averaged
from three independent ChIP experiments with each Brd and HP1
protein and data from three experiments with HEK293 genomic
chromatin.
Additional file 3: Table of relative PTM abundances determined by
quantitative mass spectrometry on the histone H4 peptide (amino
acids 4 to 17) averaged from three independent ChIP experiments
with each Brd and HP1 protein and data from three experiments
with HEK293 genomic chromatin.
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Additional file 4: P-values from t-tests performed on the fold
changes (ChIP/Genomic) from the histone H4 data presented in
Additional file 3. t-Tests were performed with data from three
independent ChIP experiments for each Brd and HP1 protein and data
from three experiments with HEK293 genomic chromatin. P-values were
adjusted using the Benjamini-Hochberg correction method to control
the false discovery rate (FDR).
Additional file 5: P-values from t-tests performed on the fold
changes (ChIP/Genomic) from the histone data presented in
Additional file 2. t-Tests were performed with data from three
independent ChIP experiments for each Brd and HP1 protein and data
from three experiments with HEK293 genomic chromatin. P-values were
adjusted using the Benjamini-Hochberg correction method to control
the false discovery rate (FDR).
Additional file 6: Table of relative combinatorial PTM abundances
determined by quantitative mass spectrometry on the histone H3
peptides (amino acids 9 to 17), (amino acids 18 to 26) and (amino
acids 27 to 40) averaged from three independent ChIP experiments
with each Brd and HP1 protein and data from three experiments
with HEK293 genomic chromatin.
Additional file 7: P-values from t-tests performed on the fold
changes (ChIP/Genomic) from the histone H3 data presented in
Additional file 6. t-Tests were performed with data from three
independent ChIP experiments for each Brd and HP1 protein and data
from three experiments with HEK293 genomic chromatin. P-values were
adjusted using the Benjamini-Hochberg correction method to control
the false discovery rate (FDR).
Additional file 8: Spreadsheets of all promoters bound by the Brd
and HP1 proteins. Promoters are ranked by P-values.
Additional file 9: Heatmap of motifs enriched in the HP1 and Brd
ChIPs. Lists of consensus sequences (motifs) are found in the matrix
used to create the heatmap (Additional file 10)
Additional file 10: Spreadsheets containing matrix used to create
the heatmap of motifs enriched in Brd and HP1 ChIPs (Additional file
9).
Additional file 11: Spreadsheets containing Gene Ontology terms
enriched in Brd and HP1 ChIPs. Gene Ontology terms are ranked by
false discovery rates (FDRs).
Additional file 12: Products from PCR reactions were run on 2%
agarose gels stained with ethidium bromide and visualized on a
Gel Doc XR system (BioRad®® Hercules, CA, USA). One half of each
PCR reaction was loaded. Gel is labeled corresponding to the templates
used for the PCR reactions: control ChIP (beads alone), Brd4 ChIP and
ChIP input DNA.
Additional file 13: Western blots of whole cell extracts from Brd4
shRNA knockdown, HP1b shRNA knockdown and control shRNA
knockdown cell lines. Blots were probed with anti-Brd4 (mAb
Epitomics, 5716), anti-HP1b (pAb Cell Signaling Technology 2613) and b-
actin control (mAb Santa Cruz, sc-81178).
Additional file 14: Supplemental Materials and methods.
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